{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-067973","form_type":"8-K","ticker":"WW","cik":"0000105319","company_name":"WW INTERNATIONAL, INC.","filed_at":"2024-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.239281+00:00","generated_at":"2026-06-04T18:44:15.527751+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"WW on track to beat Q1 fiscal 2024 guidance for Clinical subscribers","bullets":["Company disclosed to employees it expects to exceed previously issued Q1 2024 guidance for end-of-period Clinical subscribers.","Forward-looking statement subject to risks detailed in the annual report on Form 10-K filed February 28, 2024.","No specific subscriber numbers or revised guidance range provided in the disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-067973","json":"https://secwatch.observer/filing/0001193125-24-067973.json","markdown":"https://secwatch.observer/filing/0001193125-24-067973.md","text":"https://secwatch.observer/filing/0001193125-24-067973.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105319/000119312524067973/0001193125-24-067973-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105319/000119312524067973/d810567d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T18:44:15.527751+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}